𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased Plasma Levels of Brain Derived Neurotrophic Factor (BDNF) in Patients with Fibromyalgia

✍ Scribed by Lisete Haas; Luis V. C. Portela; Ana Elisa Böhmer; Jean Pierre Oses; Diogo R. Lara

Publisher
Springer
Year
2010
Tongue
English
Weight
195 KB
Volume
35
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low brain-derived neurotrophic factor (B
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
✍ A. Ciammola; J. Sassone; M. Cannella; S. Calza; B. Poletti; L. Frati; F. Squitie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Abstract Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms and by a progressive degeneration of neurons in basal ganglia and in brain cortex. Brain‐derived neurotrophic factor (BDNF) is a pro‐survival factor for striatal neurons

Association between plasma paroxetine co
Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder
✍ Norio Yasui-Furukori; Shoko Tsuchimine; Taku Nakagami; Akira Fujii; Yasushi Sato 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Recent studies have implicated brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression and in the activities of antidepressant drugs. Serum BDNF levels are lower in depressed patients and increase in response to antidepressant medications; however, no studies have examined the